NO20081084L - Arylpyridiner og fremgangsmater for deres anvendelse - Google Patents
Arylpyridiner og fremgangsmater for deres anvendelseInfo
- Publication number
- NO20081084L NO20081084L NO20081084A NO20081084A NO20081084L NO 20081084 L NO20081084 L NO 20081084L NO 20081084 A NO20081084 A NO 20081084A NO 20081084 A NO20081084 A NO 20081084A NO 20081084 L NO20081084 L NO 20081084L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- aryl pyridines
- pyridines
- aryl
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
Arylpyridiner, preparater inneholdende disse og fremgangsmåter for deres bruk for å behandle, forhindre og holde i sjakk en rekke forskjellige sykdommer og forstyrrelser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70474205P | 2005-08-02 | 2005-08-02 | |
PCT/US2006/030269 WO2007016674A2 (en) | 2005-08-02 | 2006-07-31 | 2-aminoaryl pyridines as protein kinases inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081084L true NO20081084L (no) | 2008-02-29 |
Family
ID=37517029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081084A NO20081084L (no) | 2005-08-02 | 2008-02-29 | Arylpyridiner og fremgangsmater for deres anvendelse |
Country Status (11)
Country | Link |
---|---|
US (1) | US8153804B2 (no) |
EP (1) | EP1919895A2 (no) |
JP (1) | JP2009503103A (no) |
KR (1) | KR20080040692A (no) |
CN (1) | CN101258142A (no) |
AU (1) | AU2006275403A1 (no) |
BR (1) | BRPI0614262A2 (no) |
CA (1) | CA2617413A1 (no) |
MX (1) | MX2008001538A (no) |
NO (1) | NO20081084L (no) |
WO (1) | WO2007016674A2 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3354650T1 (sl) | 2008-12-19 | 2022-06-30 | Vertex Pharmaceuticals Incorporated | Spojine, uporabne kot zaviralci ATR kinaze |
RU2012153675A (ru) | 2010-05-12 | 2014-06-20 | Вертекс Фармасьютикалз Инкорпорейтед | Соединения, пригодные в качестве ингибиторов atr киназы |
CN102947272A (zh) * | 2010-05-12 | 2013-02-27 | 沃泰克斯药物股份有限公司 | 用作atr激酶抑制剂的2-氨基吡啶衍生物 |
EP2569287B1 (en) | 2010-05-12 | 2014-07-09 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
JP5997709B2 (ja) * | 2011-03-04 | 2016-09-28 | レクシコン ファーマシューティカルズ インコーポレイテッド | Mst1キナーゼ阻害剤及びその使用方法 |
IN2014KN00929A (no) | 2011-09-30 | 2015-08-21 | Vertex Pharma | |
CN108685922A (zh) | 2011-09-30 | 2018-10-23 | 沃泰克斯药物股份有限公司 | 用atr抑制剂治疗胰腺癌和非小细胞肺癌 |
PL2833973T3 (pl) | 2012-04-05 | 2018-02-28 | Vertex Pharmaceuticals Incorporated | Związki użyteczne jako inhibitory kinazy ATR i ich terapie skojarzone |
DK2904406T3 (en) | 2012-10-04 | 2018-06-18 | Vertex Pharma | METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE |
WO2016161145A1 (en) * | 2015-03-31 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Stk4 inhibitors for treatment of hematologic malignancies |
EP3355926A4 (en) | 2015-09-30 | 2019-08-21 | Vertex Pharmaceuticals Inc. | METHOD FOR THE TREATMENT OF CANCER WITH A COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS |
EP3728230A1 (en) | 2017-12-22 | 2020-10-28 | Ravenna Pharmaceuticals, Inc. | Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors |
ES2910071T3 (es) | 2018-03-08 | 2022-05-11 | Incyte Corp | Compuestos de aminopirazina diol como inhibidores de PI3K-Y |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
US11396502B2 (en) | 2018-11-13 | 2022-07-26 | Incyte Corporation | Substituted heterocyclic derivatives as PI3K inhibitors |
US11161838B2 (en) | 2018-11-13 | 2021-11-02 | Incyte Corporation | Heterocyclic derivatives as PI3K inhibitors |
WO2020102198A1 (en) | 2018-11-13 | 2020-05-22 | Incyte Corporation | Heterocyclic derivatives as pi3k inhibitors |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0412798A3 (en) * | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
US6069766A (en) * | 1990-02-09 | 2000-05-30 | Seagate Technology, Inc. | Miniature hard disc drive having low profile actuator arm voice coil and spindle motors |
JPH0558997A (ja) | 1991-09-04 | 1993-03-09 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
SE9401353D0 (sv) | 1994-04-21 | 1994-04-21 | Pharmacia Ab | Novel antitumour compounds with antimitotic activity |
GB9525296D0 (en) | 1995-12-11 | 1996-02-07 | Merck Sharp & Dohme | Therapeutic agents |
ATE227708T1 (de) | 1996-07-10 | 2002-11-15 | Schering Corp | 1,4-disubstituierte piperdine als muskarin- antagonisten |
US5952349A (en) * | 1996-07-10 | 1999-09-14 | Schering Corporation | Muscarinic antagonists for treating memory loss |
WO1998006691A2 (en) | 1996-08-14 | 1998-02-19 | Warner-Lambert Company | Low molecular weight dendritic compounds as pharmaceutical agents |
AR009811A1 (es) * | 1996-09-26 | 2000-05-03 | Novartis Ag | Compuestos herbicidas, proceso para su produccion, proceso para la produccion de intermediarios, compuestos intermediarios para su exclusivo usoen dicho proceso, composicion que tiene actividad herbicida selectiva y proceso para el control selectivo de malas hierbas y gramineas en cultivos de planta |
DE19651099A1 (de) | 1996-12-09 | 1998-06-10 | Consortium Elektrochem Ind | Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung |
WO1999055675A1 (de) * | 1998-04-29 | 1999-11-04 | Axiva Gmbh | Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten |
JP4570057B2 (ja) | 1999-09-09 | 2010-10-27 | 三菱レイヨン株式会社 | アリールピリジン誘導体の製造法 |
US6458789B1 (en) * | 1999-09-29 | 2002-10-01 | Lion Bioscience Ag | 2-aminopyridine derivatives and combinatorial libraries thereof |
US6949571B2 (en) * | 2000-06-12 | 2005-09-27 | Eisai Co., Ltd. | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
ATE277938T1 (de) * | 2000-07-18 | 2004-10-15 | Leo Pharma As | Matrix metalloproteinase inhibitoren |
JP2002193938A (ja) * | 2000-12-01 | 2002-07-10 | Bayer Ag | 4−アリールピリジン誘導体 |
CA2450262A1 (en) * | 2001-06-12 | 2002-12-19 | Neurogen Corporation | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
US20030082191A1 (en) * | 2001-08-29 | 2003-05-01 | Poduslo Joseph F. | Treatment for central nervous system disorders |
US7304061B2 (en) * | 2002-04-26 | 2007-12-04 | Vertex Pharmaceuticals Incorporated | Heterocyclic inhibitors of ERK2 and uses thereof |
US20040082627A1 (en) * | 2002-06-21 | 2004-04-29 | Darrow James W. | Certain aromatic monocycles as kinase modulators |
US7015227B2 (en) * | 2002-06-21 | 2006-03-21 | Cgi Pharmaceuticals, Inc. | Certain amino-substituted monocycles as kinase modulators |
AU2003213397B2 (en) | 2002-07-05 | 2008-12-04 | Japan Tobacco Inc. | Sterility recovery genes to rice BT type male sterile cytoplasm |
JP4570955B2 (ja) * | 2002-07-09 | 2010-10-27 | バーテクス ファーマスーティカルズ インコーポレイテッド | プロテインキナーゼ阻害活性を持つイミダゾール類 |
JP2004107271A (ja) | 2002-07-22 | 2004-04-08 | Mitsubishi Rayon Co Ltd | 水溶性アルキルホスフィン誘導体とその製造方法、ホスフィン配位子錯体並びにビアリール誘導体の製造方法 |
EP1575919A1 (en) | 2002-11-11 | 2005-09-21 | Bayer HealthCare AG | Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
JP2004182713A (ja) | 2002-12-03 | 2004-07-02 | Api Corporation | ハロアリール置換ピリジン誘導体の製造方法 |
US20040142978A1 (en) | 2002-12-12 | 2004-07-22 | Pharmacia Corporation | Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
AU2003297160A1 (en) * | 2002-12-18 | 2004-07-22 | Vertex Pharmaceuticals Incorporated | Benzisoxazole derivatives useful as inhibitors of protein kinases |
DE10315573A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituierte Pyrazole |
AU2004233835B2 (en) | 2003-04-24 | 2010-02-25 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
EP1622616B1 (en) | 2003-04-24 | 2011-06-15 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
JP2004359642A (ja) | 2003-06-06 | 2004-12-24 | Nippon Shokubai Co Ltd | マレイミド化合物およびその製造方法 |
-
2006
- 2006-07-31 MX MX2008001538A patent/MX2008001538A/es not_active Application Discontinuation
- 2006-07-31 KR KR1020087002775A patent/KR20080040692A/ko not_active Application Discontinuation
- 2006-07-31 CA CA002617413A patent/CA2617413A1/en not_active Abandoned
- 2006-07-31 BR BRPI0614262-1A patent/BRPI0614262A2/pt not_active Application Discontinuation
- 2006-07-31 AU AU2006275403A patent/AU2006275403A1/en not_active Abandoned
- 2006-07-31 JP JP2008525185A patent/JP2009503103A/ja active Pending
- 2006-07-31 US US11/497,539 patent/US8153804B2/en active Active
- 2006-07-31 EP EP06813280A patent/EP1919895A2/en not_active Withdrawn
- 2006-07-31 WO PCT/US2006/030269 patent/WO2007016674A2/en active Application Filing
- 2006-07-31 CN CNA2006800286110A patent/CN101258142A/zh active Pending
-
2008
- 2008-02-29 NO NO20081084A patent/NO20081084L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007016674A2 (en) | 2007-02-08 |
MX2008001538A (es) | 2008-04-04 |
CN101258142A (zh) | 2008-09-03 |
JP2009503103A (ja) | 2009-01-29 |
WO2007016674A3 (en) | 2007-03-15 |
EP1919895A2 (en) | 2008-05-14 |
US8153804B2 (en) | 2012-04-10 |
KR20080040692A (ko) | 2008-05-08 |
US20070032501A1 (en) | 2007-02-08 |
CA2617413A1 (en) | 2007-02-08 |
BRPI0614262A2 (pt) | 2011-03-15 |
AU2006275403A1 (en) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081084L (no) | Arylpyridiner og fremgangsmater for deres anvendelse | |
NL301145I2 (nl) | Tirbanibulin | |
NO20083324L (no) | Multisykliske aminosyrederivater og anvendelse derav | |
NO20070908L (no) | Sammensmeltede ringheterocykelkinasemodulatorer | |
NO20092612L (no) | Forbindelser og metode for kinasemodulering og indikasjoner for dette | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
MX2009012623A (es) | Moduladores de cinasa heterociclicos. | |
NO20073628L (no) | Pyridoner som er nyttige som inhibitorer av kinaser | |
TNSN07027A1 (en) | Pyrrolo-pyridine kinase modulators | |
EA201170492A1 (ru) | Векторы для генной терапии и цитозиндезаминазы | |
DK1543011T3 (da) | Thienopyrrolyl- og furanopyrrolylforbindelser og deres anvendelse som histamin H4-receptorligander | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
ATE517896T1 (de) | P38-kinase-inhibitoren | |
ATE416177T1 (de) | Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer | |
NO20082753L (no) | Transdermalt terapeutisk system | |
EA200802213A1 (ru) | Способы лечения заболеваний крови | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
NO20073033L (no) | Cytotoksiske midler innbefattende nye taksaner | |
EA200700717A1 (ru) | Сульфонамиды | |
NO20052028L (no) | Pyridinderivater som CB2 reseptor modulatorer | |
NO20081013L (no) | 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
EA200800835A1 (ru) | Циклопропиламины в качестве модуляторов рецептора гистамина н |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |